West Virginia Clinches $17 Million Settlement from Pfizer and Ranbaxy Over Generic Drug Market Delay
CHARLESTON, W.Va. — State authorities in West Virginia have concluded a significant legal dispute with pharmaceutical giants Pfizer and Ranbaxy, accusing them of anti-competitive practices that delayed the release of a generic cholesterol medication. Announced on Thursday, this resolution resulted from allegations that the drug manufacturers conspired to keep a cheaper, generic version of the popular drug Lipitor off the market for more than eighteen months. At the core of the issue was the patent for Lipitor, which expired in 2010. However, it wasn’t until the lawsuit, filed in 2013, that the details surrounding the … Read more